Epidermal growth factor receptor (EGFR) as a potential new target in the treatment of patients with adrenocortical carcinoma: Results of pre-clinical studies No significant financial relationships to ...

Syndex Bio, a biotechnology company advancing next‑generation molecular diagnostics, today announced the introduction of its proprietary mcPCR ™ (methyl‑copying PCR) platform at the Advances in Genome ...

Regular screening practices can identify malignant disease at an early stage, which may provide promising therapeutic options for patients, resulting in improved long-term outcomes. However, for some ...

Non-Hodgkin’s Lymphoma After Primary Hodgkin’s Disease in the German Hodgkin’s Lymphoma Study Group: Incidence, Treatment, and Prognosis PURPOSE: To investigate the frequency of p15 and p16 gene ...

In this ‘Peek behind the paper’, Elena Martens-Uzunova (left), Assistant Professor in the Department of Urology at the Erasmus University Medical Center (Rotterdam, The Netherlands), discusses her ...

Syndex Bio, announced the introduction of its proprietary mcPCR™ (methyl-copying PCR) platform at the Advances in Genome Biology and Technology (AGBT) conference in Orlando, Florida. mcPCR enables ...

A streamlined urine DNA test more accurately detects primary bladder cancer, reducing the need for more invasive cystoscopy, reports The Journal of Molecular Diagnostics Lead investigator Sungwhan An, ...

The epigenetic modification, DNA methylation, is characterized by 5-methylcytosine (5-mC) and found in specific genomic locations, most notably regulatory regions such as promoters and enhancers.

DNA methylation is a fundamental epigenetic mechanism in which a methyl group is added onto a nucleotide, commonly cytosine. DNA methylation affects many biological processes, including gene ...

Methylation analysis holds significant promise for clinical diagnostics, yet its use has been limited due to challenges posed by legacy technologies that undermine clinical applicability, such as ...